Pediatric Rare Anemia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload. (NCT00390858) | Novartis Pharmaceuticals | 2003-09-01 |
Track Pediatric Rare Anemia automatically
Every clearance here is in the API, with alerts when new ones post.